While ongoing stress from COVID-19 has had an effect on many people's mental health, contracting the virus may have much more of an impact on the brain.
While ongoing stress from COVID-19 has had an affect on many people's mental health, contracting the virus may have much more of an impact on the brain.
Recent reports are showing that some people are reporting they are experiencing post-COVID-19 symptoms of cognitive changes affecting memory, way of thinking and more.
President of Western University of Health and Sciences, Daniel R. Wilson, MD, PhD, and former president of the American Neuropsychiatric Association, has been closely monitoring the impact COVID-19.
Wilson has noted the virus is "effecting the brain in a way that reduces memory or concentration (as) a classic neuropsychiatric issue."
With this particular issue being one of the many effects of COVID-19, there is still more research be done on the virus and its cognitive affects
"More research is conducted every day as we continue to learn about the long-term impact of COVID-19 on the human mind and body," Wilson says. "Recent reports showing a loss of cognitive ability could impact people's ability to maintain their quality of life, performance at their job, and more."
Should the disease start to take away cognitive ability, the next downstream effect on some people could be mild depression or apathy, he adds.
It's currently up to time itself to tell if the percentage of those who have shown a drop in cognitive function will regain cognitive ability or if things will continue to deteriorate.
Wilson says it will be important to further investigate the extent to which cognition is impacted in the weeks and months after the infection, and whether permanent damage to brain function results in some people, as researchers seek to better understand the long-term impact of COVID-19.
"No study can claim a clear conclusion, but it is imperative that people do everything they can to protect themselves from contracting and/or spreading the COVID-19 virus," Wilson adds.
The Departments of Health and Human Services (HHS), Labor, and the Treasury, released final rules on short-term, limited-duration insurance (STLDI) and independent, non-coordinated excepted benefits coverage, addressing issues related to the low-quality insurance, or "junk insurance" plans.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with Ceci Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 28th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and Ceci Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More